Evaluation of the anticonvulsant activity of ethanol leaf extract of Panicum maximum in pentylenetetrazole and strychnine induced seizure in mice.
DOI:
https://doi.org/10.54117/jcbr.v3i4.4Keywords:
Anticonvulsant, mice, Panicum maximum, pentylenetetrazole, strychnineAbstract
Epilepsy is a chronic neurological condition affecting around 50 million people worldwide. This study evaluated the anticonvulsant effect of Panicium maxmium in pentylenetetrazole (PTZ) and strychnine (STN) induced convulsions in mice. For each model, 25 mice were divided into five groups; group 1 received 10 ml/kg distilled water, groups 2-4 received 100 mg/kg, 200 mg/kg and 400 mg/kg of extract p.o respectively. Group 5 received 3 mg/kg of diazepam p.o. Convulsion was induced intraperitoneally using PTZ and STN, thirty minutes after the extract was administered. The onset of myoclonic, tonic-clonic seizure, time of death within 60 minutes of PTZ and STN administration were monitored. Data were statistically analyzed using one-way ANOVA followed by Dunnet’s comparison tests. In STN-induced seizure model, 100 mg/kg of P. maximum exhibited a significant (p < 0.001) anticonvulsant activity by delaying myoclonic seizure onset in mice when compared to the control. Significant (p < 0.001) activity was also observed in the onset of tonic clonic seizure at same dose when compared to control. In PTZ-induced seizure model, 200 mg/kg exhibited more significant (p < 0.001) activity followed by 100 mg/kg (p < 0.05) by delaying myoclonic seizure onset in mice when compared to the control. Significant (p < 0.001) activity were observed in tonic clonic phase at same doses respectively. The different doses administered couldn’t protect the mice from death. Diazepam, standard drug used, protected all the animals without any signs of convulsions. The results provide evidence that the extract possesses anticonvulsant activity.
Published
Issue
Section
Categories
License
All articles in JCBR are published under CC BY 4.0. Authors retain copyright of their articles. The Journal of Current Biomedical Research (JCBR) publishes all articles under the Creative Commons Attribution 4.0 International license (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, for any purpose, provided appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes are indicated. The Version of Record should be cited with its DOI.
License: https://creativecommons.org/licenses/by/4.0/